Listen to our CEO talk about cancer in our pets and how CAVU is solving this problem on NPR's Bauer Business Focus.

December 20, 2017

Houston, TX– CAVU Biotherapies was recently recognized as one of the “Best Entrepreneurial Companies in America” by Entrepreneur magazine’s Entrepreneur360™ List, a premier study delivering the most comprehensive analysis of private companies in America. Based on this study forged by Entrepreneur, CAVU Biotherapies is recognized as a well-rounded company that has mastered a balance of impact, innovation, growth and leadership.

"I am thrilled to have CAVU recognized as one of the best entrepreneurial companies in America.  It is a testimony to great teamwork, the city of Houston's entrepreneurial support,  and the passion to help our dogs overcome cancer through new personalized therapies," stated Dr. Colleen O'Connor, CEO of CAVU Biotherapies.

​

“Our annual evaluation is a 360-degree analysis of top privately-held companies representing and serving a variety of industries,” explains Lisa Murray, Chief Insights Officer of Entrepreneur Media, Inc. “These businesses are real-world case studies for any entrepreneur who seeks to master the four pillars that can greatly impact the longevity and growth of their businesses. With the Entrepreneur 360, success is measured by achieving balance throughout the entire organization, predicated by revenue.”

CAVU Biotherapies is a Houston, TX-based, USDA authorized, veterinary biotech company focused on modernizing cancer care for dogs using personalized therapies with veterinary oncology providers located in California, Texas, and Florida. CAVU's services enable owners to plan ahead for their dogs T-cell based cancer care and veterinarians to tailor treatments to the individual by using greater knowledge of the patient's immune system.

Honorees were identified based on the results from a comprehensive study of independently- owned companies, using a proprietary algorithm and other advanced analytics. The algorithm was built on a balanced scorecard designed to measure four metrics reflecting major pillars of entrepreneurship—innovation, growth, leadership and impact.

To learn more about CAVU Biotherapies, visit: www.cavubiotherapies.com.

For additional details on the E360 List and the companies recognized, visit: entrepreneur.com/360

​

July 25, 2017

Dr. O'Connor was featured in the Gold Medal Winner of the 2016 Independent Publishers Book Award, "HEAL" by Arlene Weintraub.  In the book,  Dr. O'Connor explains her extensive experience with canine T-cell therapy and doing the world's first T-cell infusion into a pet dog with cancer,  tumor involved immune system dysfunction, and the development of CAR T-cell therapy for dogs living with cancer.  She talks about how T-cell therapy and immunotherapy is the future for our dogs.

July 09, 2017

CAVU Biotherapies wins at the NexGen Rapid Fire Pitch Competition and proceeds to the second round where we will pitch in front of investors.

June 25, 2017

CEO, Colleen O'Connor,PhD, uses Star Wars to explain cancer and the immune system to kid judges with success.

June 12, 2017

There’s some good news coming out of Washington, DC this week for children and pets. I just returned from the Paws for a Cure meeting which was groundbreaking. Those of us working in the word of cancer know that dogs and kids develop many of the same cancers, but efforts to find a cure are not widely shared. We are now working to change that.

June 09, 2017

2017 InnovateHER: Innovating for Women Business Challenge, a nationwide business competition to drive attention and resources to innovative products and services that make our lives easier and longer.  Competitors vie for $70,000 in prize money provided to SBA for the InnovateHER competition through a gift from the Sara Blakely Foundation. 2017 InnovateHER Challenge is designed to help identify products and services that impact and empower the lives of women and families.

May 30, 2017

CAVU Biotherapies has new laboratory space at the University of Houston Innovation Center where "Start-ups Start-up".

May 17, 2017

Start-up Grind Houston celebrated Women Entrepreneurs with a juried pitch competition and excellent fireside chats with women entrepreneurs and leaders from the University of Houston School of Business.

February 01, 2017

Dr. Colleen O'Connor, Founder and CEO of CAVU Biotherapies, was named a finalist for Entrepreneur of the Year award by the Business Excellence Forum and Awards. 

November 18, 2016

From Comcast Business: 

Women’s Entrepreneurship Day takes place annually each November and allows a unique opportunity to celebrate women in business. We spoke with several female executives to get their thoughts on the issues women business owners face. Here’s what they had to say. 

August 30, 2016

"It's the combination of academia and the industry," Colleen O'Connor says of UH's new wet lab business incubator. O'Connor is founder and CEO of CAVU Biotherapies.

August 01, 2016

As part of Innovations 4 Entrepreneurs (I4E) Tech Week, we interviewed some of the 2016 I4E Grand Prize Contest Winners to learn more about being an entrepreneur and the technologies that impact their businesses.

In this episode, Dr. Colleen O’Connor from CAVU Biotherapies shares her goals for growing her business and helping to treat and cure cancer in pets.

June 14, 2016

Nature News writes "Firms chase a new breed of advanced veterinary care, from antibodies to cell therapies."

June 22, 2016

Dr. Colleen O'Connor tapes a 10 minute pitch on CAVU Biotherapies.

March 03, 2017

Information about CAVU Biotherapies and Texas A&M University's new clinical trial for pet dog's diagnosed with B-cell lymphoma.

October 27, 2015

CAVU Biotherapies is accepted in the Houston Technology Center's Life Science Accelerator